Deadly confusion of novel psychoactive substances: fatal outcome of ADB-BUTINACA mislabeled as 3’,4’-methylenedioxy-α-pyrrolidinohexiophenone
Open Access
- 27 November 2025
- journal article
- case report
- Published by Springer Nature in Forensic Toxicology
- Vol. 44 (1) , 257-270
Abstract
Purpose: A powder found at a fatality scene, labeled as the synthetic cathinone 3’,4’-methylenedioxy-α-pyrrolidinohexiophenone (MDPHP) and most likely smoked using a crack pipe, was analyzed. The powder was identified as very potent synthetic cannabinoid ADB-BUTINACA/ADB-BINACA with a high purity (> 98%). This case highlights the risks associated with mislabeled novel psychoactive substances (NPS), particularly those purchased online. Methods: The powder was analyzed using liquid chromatography-high resolution mass spectrometry (LC-HRMS), liquid chromatography-tandem mass spectrometry (LC-MS/MS), and nuclear magnetic resonance (NMR) spectroscopy. Comprehensive toxicological screening, including NPS, was performed in urine and blood. ADB-BUTINACA was quantified using a standard addition method on various post-mortem matrices: femoral and heart blood, urine, stomach content, bile fluid and liver tissue. Scalp hair was analyzed via external calibration to assess potential long-term exposure. Results: ADB-BUTINACA concentrations were 34.5 ng/mL in femoral blood, 101 ng/mL in heart blood and 3.1 ng/mL in urine. Traces of MDMB-BUTINACA were found in the powder and hair, but not in other biological matrices. ADB-BUTINACA metabolites were detected in all biological matrices. MDPHP was found at low concentrations (< 2 ng/mL) in blood and urine but not in the powder, indicating prior cathinone use. A toxicological significance score (TSS) of 3 was assigned for this monointoxication with ADB-BUTINACA. Conclusions: This case demonstrates fatal poisoning due to extremely high ADB-BUTINACA concentrations in post-mortem blood samples, emphasizing the severe risks associated with mislabeled substances. It underscores the importance of drug checking services to prevent poisonings and overdoses caused by highly potent NPS.Keywords
Funding Information
- Universitätsklinikum Freiburg
This publication has 58 references indexed in Scilit:
- Three fatalities associated with the synthetic cannabinoids 5F-ADB, 5F-PB-22, and AB-CHMINACAForensic Science International, 2017
- Assessing the toxicological significance of new psychoactive substances in fatalitiesDrug Testing and Analysis, 2017
- Immunoassay screening in urine for synthetic cannabinoids – an evaluation of the diagnostic efficiencyClinical Chemistry and Laboratory Medicine (CCLM), 2017
- Metabolites of synthetic cannabinoids in hair—proof of consumption or false friends for interpretation?Analytical and Bioanalytical Chemistry, 2016
- Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse PotentialCurrent Addiction Reports, 2014
- A comprehensive library‐based, automated screening procedure for 46 synthetic cannabinoids in serum employing liquid chromatography‐quadrupole ion trap mass spectrometry with high‐temperature electrospray ionizationJournal of Mass Spectrometry, 2014
- Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9-THC: Mechanism underlying greater toxicity?Life Sciences, 2014
- Stability of 11 prevalent synthetic cannabinoids in authentic neat oral fluid samples: glass versus polypropylene containers at different temperaturesDrug Testing and Analysis, 2013
- Differentiation between drug use and environmental contamination when testing for drugs in hairForensic Science International, 2008
- Influence of the cosmetic treatment of hair on drug testingInternational journal of legal medicine, 1997